A 41-year-old man presents to the primary care clinic for evaluation of elevated blood pressure. He has a 3-year history of hypertension that has been difficult to control despite strict adherence to a regimen of maximum tolerated doses of lisinopril, amlodipine, and hydrochlorothiazide. The patient notes occasional episodes of muscle cramping and generalized weakness but denies headaches, palpitations, or diaphoresis. His blood pressure is 168/102 mm Hg, and his pulse is 76/min. The physical examination is unremarkable, with no abdominal bruits or peripheral edema.
Initial laboratory studies reveal the following:
| Laboratory Parameter | Result | Reference Range |
|---|---|---|
| Sodium | 144 mEq/L | 136-145 mEq/L |
| Potassium | 3.1 mEq/L | 3.5-5.0 mEq/L |
| Chloride | 102 mEq/L | 95-105 mEq/L |
| Bicarbonate | 29 mEq/L | 22-28 mEq/L |
| Blood urea nitrogen | 15 mg/dL | 7-18 mg/dL |
| Creatinine | 0.8 mg/dL | 0.7-1.3 mg/dL |
Which of the following is the most appropriate next step in laboratory evaluation?
- AComputed tomography of the abdomen
- Measurement of plasma aldosterone concentration to plasma renin activity ratioAnswer
- COral sodium loading test
- D24-hour urine collection for fractionated metanephrines
- EAdrenal venous sampling
Answer
Measurement of plasma aldosterone concentration to plasma renin activity ratio
The correct answer identifies the primary screening test for primary hyperaldosteronism. This patient presents with classic features: resistant hypertension, hypokalemia, and metabolic alkalosis. According to established endocrine guidelines, the most appropriate initial laboratory evaluation is measuring the plasma aldosterone concentration to plasma renin activity ratio. A high ratio (typically > 20) with a concurrent plasma aldosterone concentration > 15 ng/dL indicates a positive screen, prompting subsequent confirmatory testing.
Step-by-Step Solution
Key Concept
The initial diagnostic step for suspected primary hyperaldosteronism is screening with the plasma aldosterone concentration to plasma renin activity ratio.